A Hopeful Alternative “therapy With Intra- Nasal Esketamine in a Patient With Resistant Depression”. a Case Report.
Year: 2023
Type: article
Study design: Case Report
Abstract: Major Depressive Disorder is the leading cause of disability worldwide. Treatment-resistant depression occurs in a subgroup of patients with this disorder, and consists of a lack of response to two or more different antidepressants under adequate doses and duration, with optimal adherence to treatment.
Source: PubMed Central
Authors: Rosa M Galán-Armenteros, María C Romero-Mohedano, Cristina González-González, María A Marco-Feced, Antonio J Moreno-Campos
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4387516307